IL15 and neoplasm: The immense impact of IL-15 as an independent marker for predicting the survival outcome is furthermore underlined by the fact that even in the patient collective with favourable tumor characteristics at primary diagnosis, such as CTC negativity, no lymph node involvement or triple-positive breast cancer, and increased serum IL-15 concentrations were significantly increased in those patients that deceased.